PSI

   |   

   |   

   |   

   |   


Home PSI About Us Full Service Contract Research Organization (CRO) Global Reach On-Time Enrollment Therapeutic Excellence Contract Research Organization (CRO) News

Case Studies     |     Allergy, Immunology & Rheumatology    |    Cardiology      |     Central Nervous System     |    Endocrine & Metabolic     |     Gastroenterology

Hematology     |     Infectious Disease     |     Oncology     |     Nephrology & Urology     |     Pediatrics     |     Respiratory

Therapeutic Excellence
Email Page Print Page

Breast Cancer Clinical Trials


One of the core PSI clinical trial strengths is predictable patient enrollment across numerous therapeutic areas. This includes a variety of oncology indications, one of which is breast cancer.


Breast cancer clinical trials are one of the therapeutic indications in which PSI project management philosophy has proven effective time after time. The PSI clinical team effectively manage site relationships, support PSI investigators and meet enrollment goals.


Recognizing the challenges in these type of clinical trials, PSI selects highly-experienced professional investigators who can pool a sufficient number of patients from the target population in advance. The Actual vs. Planned enrollment graphs below presents PSI’s continued on-time enrollment performance.


For more information on PSI’s clinical trial experience in this therapeutic area, please contact us.

 


Graph 1: Phase III Breast Cancer
Graph 1: Phase III Breast Cancer
Graph 2: Phase III Breast Cancer
Graph 2: Phase III Breast Cancer
Graph 3: Phase II Breast Cancer
Graph 3: Phase II Breast Cancer


About PSI Full Service CRO Global Reach On-Time Enrollment Therapeutic Excellence News
Full Name
Email
Details

© PSI, 1995-2012. All rights reserved. | Terms of Access | Disclaimer | Privacy Policy | Sitemap

PSI on Xing PSI on Twitter PSI on Facebook PSI on Linkedin News Archives